Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Respiratory · Respir Med · 2026-09-25
RCTn = 78
Simeone et al. Losartan with add-on spironolactone for severe COVID-19 in the intensive care unit: a randomized controlled trialCardiology · Eur J Heart Fail · 2026-09-15
Secondary analysisn = 1,648
Beldhuis et al. Spironolactone, early acute eGFR changes, and clinical outcomes in patients with heart failure with preserved ejection fraction: insights from TOPCAT AmericasCardiology · Eur J Heart Fail · 2026-09-15
Meta-analysisn = 10,644
Bagattoli et al. Finerenone, eplerenone, and spironolactone in heart failure with preserved ejection fraction: a Bayesian network meta-analysis of efficacy and safetyCardiology · JACC Heart Fail · 2026-05-26
Secondary analysisn = 106
Ferreira et al. Renin, Aldosterone, and Treatment Response to Dapagliflozin, Spironolactone, and Their Combination: An Analysis From SOGALDI-PEFCardiology · J Am Heart Assoc · 2026-03-18
Secondary analysisn = 757
Zang et al. Left Atrial Volume Index and Left Ventricular Mass Index Determine the Benefits of Spironolactone in Patients With Heart Failure With Preserved Ejection FractionDermatology · J Eur Acad Dermatol Venereol · 2026-03-18
Guideline
Nast et al. Update of the EuroGuiDerm evidence-based guideline for the treatment of acne-Short version